Financial Year |
March 31 2023 |
Monetary Funds |
30,163,672.04 |
Held-for-trading Financial Assets |
31,579,566.63 |
Notes Receivable |
-- |
Accounts Receivable |
7,788,508.36 |
Advances to Suppliers |
17,313,179.87 |
Other Receivables |
7,667,053.08 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
20,390,920.18 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,333,698.56 |
Total Current Assets |
124,236,598.72 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
2,001,095.43 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
6,453,615.03 |
R&D expenses |
-- |
Goodwill |
21,092,307.10 |
Long-Term Deferred and Prepaid Expenses |
1,820,742.87 |
Deferred Income Tax Assets |
7,544,541.75 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
48,394,410.03 |
Total Assets |
172,631,008.75 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
788,555.16 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
6,946,173.39 |
Taxes Payable |
7,701,832.15 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
15,552,140.72 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,634,582.83 |
Other Current Liabilities |
558,533.41 |
Sub-Total of Current Liabilities |
44,971,458.50 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,670,372.94 |
Total Liabilities |
46,641,831.44 |
Paid-In Capital(Or Share Stock) |
130,065,904.00 |
Capital Surplus |
159,465,577.63 |
Surplus Reserve |
17,068,098.65 |
LESS:Treasury Stock |
46,645,474.71 |
Undistributed Profits |
-133,964,928.26 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
125,989,177.31 |
Owner's Equity(Stockholder's Equity) |
125,989,177.31 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
172,631,008.75 |